Precigen (PGEN) News Today $0.69 +0.02 (+2.98%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Inovio Pharmaceuticals: The Dangerous Allure Of A Falling KnifeDecember 15 at 3:21 PM | seekingalpha.comPrecigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Moderate Buy" by BrokeragesShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and four have given a buy rating to the comDecember 1, 2024 | marketbeat.comPrecigen's SWOT analysis: biotech stock focuses on RRP treatmentNovember 27, 2024 | uk.investing.comPrecigen Reports Q3 2024 Financial ResultsNovember 22, 2024 | tipranks.comPrecigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%November 20, 2024 | finance.yahoo.comHC Wainwright Reduces Earnings Estimates for PrecigenPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 earnings estimates for shares of Precigen in a research report issued on Friday, November 15th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will postNovember 18, 2024 | marketbeat.comPrecigen, Inc. (PGEN) Stock Price, News, Quote & History - Yahoo FinanceNovember 17, 2024 | finance.yahoo.comPrecigen’s Promising Developments and Strategic Focus Drive Buy RatingNovember 15, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Precigen (PGEN)November 15, 2024 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN)HC Wainwright restated a "buy" rating and issued a $4.00 price objective on shares of Precigen in a report on Friday.November 15, 2024 | marketbeat.comPrecigen, Inc.: Precigen Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 15, 2024 | finanznachrichten.dePrecigen’s Strategic Advancements and FDA Alignment Bolster Buy RatingNovember 15, 2024 | markets.businessinsider.comPrecigen Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 14, 2024 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving Average - Here's WhyPrecigen (NASDAQ:PGEN) Share Price Crosses Below Two Hundred Day Moving Average - Here's WhyNovember 14, 2024 | marketbeat.comPrecigen to Participate in the Stifel 2024 Healthcare ConferenceNovember 12, 2024 | finance.yahoo.comPrecigen to Participate in the Stifel 2024 Healthcare ConferenceNovember 12, 2024 | prnewswire.comIridian Asset Management LLC CT Has $3.58 Million Stock Position in Precigen, Inc. (NASDAQ:PGEN)Iridian Asset Management LLC CT raised its stake in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 82.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,775,960 shares of the biotechnology cOctober 31, 2024 | marketbeat.comShould you Hold Precigen (PGEN)?October 18, 2024 | msn.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Rating of "Moderate Buy" by BrokeragesPrecigen, Inc. (NASDAQ:PGEN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the comOctober 12, 2024 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving Average of $1.36Precigen (NASDAQ:PGEN) Stock Crosses Below Two Hundred Day Moving Average of $1.36October 3, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Inspire Medical Systems (INSP) and Precigen (PGEN)October 1, 2024 | markets.businessinsider.comPrecigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been given an average rating of "Moderate Buy" by the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and four have assigned a buySeptember 17, 2024 | marketbeat.comPrecigen to Participate in the 2024 Cantor Global Healthcare ConferenceSeptember 16, 2024 | prnewswire.com3 Penny Stocks To Buy With Just $50September 15, 2024 | 247wallst.comWhile institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 43% ownershipSeptember 12, 2024 | finance.yahoo.com3 Penny Stocks to Buy With $500August 30, 2024 | 247wallst.comPrecigen, Inc. (NASDAQ:PGEN) Given Average Recommendation of "Moderate Buy" by BrokeragesPrecigen, Inc. (NASDAQ:PGEN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and four have issued a buy rating on the coAugust 23, 2024 | marketbeat.comQ3 2024 EPS Estimates for Precigen, Inc. (NASDAQ:PGEN) Raised by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Investment analysts at HC Wainwright boosted their Q3 2024 EPS estimates for shares of Precigen in a research note issued on Thursday, August 15th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will earn ($0.07) per sharAugust 19, 2024 | marketbeat.comPrecigen Second Quarter 2024 Earnings: Misses ExpectationsAugust 17, 2024 | finance.yahoo.comPrecigen, Inc. (NASDAQ:PGEN) to Post FY2026 Earnings of $0.02 Per Share, HC Wainwright ForecastsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Analysts at HC Wainwright dropped their FY2026 EPS estimates for shares of Precigen in a report released on Thursday, August 15th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings per share of $0.02 for tAugust 16, 2024 | marketbeat.comBuy Rating Affirmed for Precigen Amid Promising PRGN-2012 Clinical Data and Strategic FocusAugust 15, 2024 | markets.businessinsider.comPrecigen (NASDAQ:PGEN) Given New $7.00 Price Target at JMP SecuritiesJMP Securities decreased their price target on Precigen from $14.00 to $7.00 and set a "market outperform" rating on the stock in a research note on Thursday.August 15, 2024 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comPrecigen, Inc.: Precigen Reports Second Quarter and First Half 2024 Financial Results and Business UpdatesAugust 15, 2024 | finanznachrichten.deWhy Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving PremarketAugust 15, 2024 | msn.comPGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comPrecigen Reports Second Quarter and First Half 2024 Financial Results and Business UpdatesAugust 14, 2024 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) SVP Acquires $49,999.55 in StockAugust 14, 2024 | insidertrades.comPrecigen earnings: here's what Wall Street expectsAugust 14, 2024 | markets.businessinsider.comWeekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal SprayAugust 11, 2024 | nasdaq.comPrecigen (PGEN) Scheduled to Post Quarterly Earnings on WednesdayPrecigen (NASDAQ:PGEN) will be releasing earnings after the market closes on Wednesday, August 14, Zacks reports.August 10, 2024 | marketbeat.comPrecigen to Announce Second Quarter and First Half 2024 Financial Results on August 14thAugust 9, 2024 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Pass Below 200-Day Moving Average of $1.47Precigen (NASDAQ:PGEN) Stock Crosses Below Two Hundred Day Moving Average of $1.47August 9, 2024 | marketbeat.comPrecigen Announces Pricing of $30.0 Million Public Offering of Common StockAugust 7, 2024 | prnewswire.comBuy Rating Backed by Strategic Focus and Solid Clinical Pipeline at PrecigenAugust 7, 2024 | markets.businessinsider.comPrecigen to shed 20% of workforce, focus on PRGN-2012 gene therapyAugust 6, 2024 | seekingalpha.comPrecigen Announces Proposed $30 Million Public Offering of Common StockAugust 6, 2024 | prnewswire.comPrecigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy LaunchAugust 6, 2024 | prnewswire.comPrecigen (NASDAQ:PGEN) Upgraded at StockNews.comStockNews.com raised shares of Precigen to a "sell" rating in a research note on Thursday.August 1, 2024 | marketbeat.comPrecigen, Inc.'s (NASDAQ:PGEN) Shift From Loss To ProfitJuly 31, 2024 | finance.yahoo.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼-1.140.72▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼12▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CDMO News Today IMNM News Today KROS News Today KURA News Today TYRA News Today ERAS News Today EOLS News Today RAPP News Today DNTH News Today CVAC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
